Prevalence and possible causes of hypouricemia at a tertiary care hospital
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to investigate the prevalence and possible causes of hypouricemia in the Korean population and to compare our findings with published results of other populations. Methods: We examined the serum uric acid levels of 30,757 subjects who had their uric acid values measured at least once during a 1-year period. All individuals with hypouricemia (serum uric acid < 2.0 mg/dL, n = 424) were reviewed with respect to medical drug history and concomitant diseases previously identified as being associated with hypouricemia. Results: The prevalence of hypouricemia was 4.14% (299/7,223) among inpatients and 0.53% (125/23,534) among outpatients, for an overall prevalence of 1.39% (424/30,757). Possible causes associated with hypouricemia were found to be solid or hematologic malignancies (n = 86), diabetes mellitus (n = 56), and therapeutic drugs (n = 29). The medications were allopurinol (n = 11), angiotensin II receptor blockers (n = 10), salicylates (n = 6), febuxostat (n = 1), and warfarin (n = 1). In the remaining 226 individuals, the cause of hypouricemia was not identified. Conclusions: Hypouricemia is relatively common in the Korean population compared to those of other countries. The possible causes associated with hypouricemia are related to underlying diseases and medications.
Abstract
Background/Aims: We aimed to investigate the prevalence and possible causes of hypouricemia in the Korean population and to compare our findings with published results of other populations. Methods: We examined the serum uric acid levels of 30,757 subjects who had their uric acid values measured at least once during a 1-year period. All individuals with hypouricemia (serum uric acid < 2.0 mg/dL, n = 424) were reviewed with respect to medical drug history and concomitant diseases previously identified as being associated with hypouricemia. Results: The prevalence of hypouricemia was 4.14% (299/7,223) among inpatients and 0.53% (125/23,534) among outpatients, for an overall prevalence of 1.39% (424/30,757). Possible causes associated with hypouricemia were found to be solid or hematologic malignancies (n = 86), diabetes mellitus (n = 56), and therapeutic drugs (n = 29). The medications were allopurinol (n = 11), angiotensin II receptor blockers (n = 10), salicylates (n = 6), febuxostat (n = 1), and warfarin (n = 1). In the remaining 226 individuals, the cause of hypouricemia was not identified. Conclusions: Hypouricemia is relatively common in the Korean population compared to those of other countries. The possible causes associated with hypouricemia are related to underlying diseases and medications.
참고문헌 (30)
- Esparza Martin N, "Hypouricemia and tubular transport of uric acid", Nefrologia, 31, pp.44~50 (2011)
- Sebesta I, "Diagnostic tests for primary renal hypouricemia", Nucleosides Nucleotides Nucleic Acids, 30, pp.1112~1116 (2011)
- 김현숙, "Carpal tunnel syndrome caused by tophaceous gout", The Korean Journal of Internal Medicine, 29(4), pp.544~545 (2014), 대한내과학회[DOI]
- 박준원, "Clinical factors and treatment outcomes associated with failure in the detection of urate crystal in patients with acute gouty arthritis", The Korean Journal of Internal Medicine, 29(3), pp.361~369 (2014), 대한내과학회[DOI]
- Takahashi T, "Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese", Pediatr Nephrol, 20, pp.576~578 (2005)
- Cheong HI, "Mutational analysis of idiopathic renal hypouricemia in Korea", Pediatr Nephrol, 20, pp.886~890 (2005)
- Ichida K, "Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion", J Am Soc Nephrol, 15, pp.164~173 (2004)
- Iwai N, "A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese", Kidney Int, 66, pp.935~944 (2004)
- Hamajima N, "Serum uric acid distribution according to SLC22A12W258X genotype in a cross-sectional study of a general Japanese population", BMC Med Genet, 12, pp.33~ (2011)
- Shen H, "Recurrent exercise-induced acute kidney injury by idiopathic renal hypouricemia with a novel mutation in the SLC2A9 gene and literature review", BMC Pediatr, 14, pp.73~ (2014)
- Jeannin G, "Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity", BMC Med Genet, 15, pp.3~ (2014)
- Lawee D, "Uric acid: the clinical application of 1000 unsolicited determinations", Can Med Assoc J, 100, pp.838~841 (1969)
- Ramsdell CM, "The clinical significance of hypouricemia", Ann Intern Med, 78, pp.239~242 (1973)
- Yanase M, "Prevalence of hypouricemia in apparently normal population", Nephron, 48, pp.80~ (1988)
- Hisatome I, "Cause of persistent hypouricemia in outpatients", Nephron, 51, pp.13~16 (1989)
- Casas E, "Prevalence, physiopathology and processes as-sociated with hypouricemia in a hospitalized population:analysis of 27,987 analytic determinations", Rev Clin Esp, 186, pp.211~215 (1990)
- Ogino K, "Clinical significance of hypouricemia in hospitalized patients", J Med, 22, pp.76~82 (1991)
- Bairaktari ET, "Hypouricemia in individuals admitted to an inpatient hospital-based facility", Am J Kidney Dis, 41, pp.1225~1232 (2003)
- Bugdayci G, "Causes of hypouricemia among outpatients", Lab Med, 39, pp.550~552 (2008)
- Lee JH, "Prevalence of hypouricaemia and SLC22A12 mutations in healthy Korean subjects", Nephrology, 13, pp.661~666 (2008)
- Johnson RJ, "Uric acid and diet: insights into the epidemic of cardiovascular disease", N Engl J Med, 350, pp.1071~1073 (2004)
- Lesmes A, "Tumoural hypouricemia", Adv Exp Med Biol, 122A, pp.145~148 (1980)
- Kelly WN, "Hypouricemia", Arthritis Rheum, 18(6 Suppl), pp.731~737 (1975)
- Shichiri M, "Diabetic renal hypouricemia", Arch Intern Med, 147, pp.225~228 (1987)
- Bo S, "Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes", Eur J Clin Invest, 31, pp.318~321 (2001)
- Nakamura A, "Renal hypouricemia in school-aged children: screening of serum uric acid level before physical training", Pediatr Nephrol, 21, pp.1898~1900 (2006)
- Ames BN, "Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis", Proc Natl Acad Sci U S A, 78, pp.6858~6862 (1981)
- Sebesta I, "Purine disorders with hypouricemia", Prilozi, 35, pp.87~92 (2014)
- Stiburkova B, "Novel allelic variants and evidence for a prevalent mutation in URAT1causing renal hypouricemia: biochemical, genetics and functional analysis", Eur J Hum Genet, 21, pp.1067~1073 (2013)
- Vitart V, "SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout", Nat Genet, 40, pp.437~442 (2008)